Showing 1 - 18 results of 18 for search 'D. de Araujo', query time: 0.06s
Refine Results
-
1
-
2
-
3
Targeting STAT3 and STAT5 in Cancer by Elvin D. de Araujo, György M. Keserű, Patrick T. Gunning, Richard Moriggl
Published 2020-07-01
Article -
4
-
5
-
6
-
7
-
8
-
9
Revascularización carotídea con stent: implicaciones clínicas y para el procedimiento de la presencia de una lesión suboclusiva by R.J. Ruiz-Salmerón, M.A. Gamero, C. Carrascosa, S. Pérez, D. de Araujo, F. Marcos, S. Rodríguez de Leiras, M. Vizcaíno, C. Caparrós, G. Izquierdo
Published 2013-11-01
Article -
10
-
11
Efficacy and Synergy of Small Molecule Inhibitors Targeting <i>FLT3</i>-ITD<sup>+</sup> Acute Myeloid Leukemia by Javier Bregante, Anna Schönbichler, Daniel Pölöske, Lina Degenfeld-Schonburg, Garazi Monzó Contreras, Emir Hadzijusufovic, Elvin D. de Araujo, Peter Valent, Richard Moriggl, Anna Orlova
Published 2021-12-01
Article -
12
Significância de anticorpos vibriocidas circulantes em área pós-epidêmica de diarréia, São Bento do Una, Estado de Pernambuco The importance of circulating vibriocidal antibodies i... by Lúcia Roberta de Souza Filizola, Ângela Cristina Torres de Araújo Figueirôa, Maria Cristina D. de Araújo, Valdelúcia de Oliveira Cavalcanti, Cristiani Maria de Lima, Ernesto Hofer
Published 2007-12-01
Article -
13
-
14
Restricted feeding modulates peripheral clocks and nutrient sensing pathways in rats by Luis Guilherme F. Rodrigues, Leonardo D. de Araujo, Silvia L. R. Roa, Ana C. Bueno, Ernane T. Uchoa, José Antunes-Rodrigues, Ayrton C. Moreira, Lucila L. K. Elias, Margaret de Castro, Clarissa S. Martins
Published 2021-09-01
Article -
15
High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell Lymphoma by Harsimran Kaur Garcha, Nabanita Nawar, Helena Sorger, Fettah Erdogan, Myint Myat Khine Aung, Abootaleb Sedighi, Pimyupa Manaswiyoungkul, Hyuk-Soo Seo, Susann Schönefeldt, Daniel Pölöske, Sirano Dhe-Paganon, Heidi A. Neubauer, Satu M. Mustjoki, Marco Herling, Elvin D. de Araujo, Richard Moriggl, Patrick T. Gunning
Published 2022-10-01
Article -
16
STAT5 is Expressed in CD34<sup>+</sup>/CD38<sup>−</sup> Stem Cells and Serves as a Potential Molecular Target in Ph-Negative Myeloproliferative Neoplasms by Emir Hadzijusufovic, Alexandra Keller, Daniela Berger, Georg Greiner, Bettina Wingelhofer, Nadine Witzeneder, Daniel Ivanov, Emmanuel Pecnard, Harini Nivarthi, Florian K. M. Schur, Yüksel Filik, Christoph Kornauth, Heidi A. Neubauer, Leonhard Müllauer, Gary Tin, Jisung Park, Elvin D. de Araujo, Patrick T. Gunning, Gregor Hoermann, Fabrice Gouilleux, Robert Kralovics, Richard Moriggl, Peter Valent
Published 2020-04-01
Article -
17
Structural and functional consequences of the STAT5BN642H driver mutation by Elvin D. de Araujo, Fettah Erdogan, Heidi A. Neubauer, Deniz Meneksedag-Erol, Pimyupa Manaswiyoungkul, Mohammad S. Eram, Hyuk-Soo Seo, Abdul K. Qadree, Johan Israelian, Anna Orlova, Tobias Suske, Ha T. T. Pham, Auke Boersma, Simone Tangermann, Lukas Kenner, Thomas Rülicke, Aiping Dong, Manimekalai Ravichandran, Peter J. Brown, Gerald F. Audette, Sarah Rauscher, Sirano Dhe-Paganon, Richard Moriggl, Patrick T. Gunning
Published 2019-06-01
Article -
18
Blocking STAT3/5 through direct or upstream kinase targeting in leukemic cutaneous T‐cell lymphoma by Helena Sorger, Saptaswa Dey, Pablo Augusto Vieyra‐Garcia, Daniel Pölöske, Andrea R Teufelberger, Elvin D deAraujo, Abootaleb Sedighi, Ricarda Graf, Benjamin Spiegl, Isaac Lazzeri, Till Braun, Ines Garces de los Fayos Alonso, Michaela Schlederer, Gerald Timelthaler, Petra Kodajova, Christine Pirker, Marta Surbek, Michael Machtinger, Thomas Graier, Isabella Perchthaler, Yi Pan, Regina Fink‐Puches, Lorenzo Cerroni, Jennifer Ober, Moritz Otte, Jana D Albrecht, Gary Tin, Ayah Abdeldayem, Pimyupa Manaswiyoungkul, Olasunkanmi O Olaoye, Martin L Metzelder, Anna Orlova, Walter Berger, Marion Wobser, Jan P Nicolay, Fiona André, Van Anh Nguyen, Heidi A Neubauer, Roman Fleck, Olaf Merkel, Marco Herling, Ellen Heitzer, Patrick T Gunning, Lukas Kenner, Richard Moriggl, Peter Wolf
Published 2022-12-01
Article